💊 Pharmaceuticals — Top Stocks by Market Cap
1,859 companies · updated every 5–20 min
| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 301 | ¥3562.00 | +0.39% | +0.58% | ¥416.69B $2.79B · €2.50B | 1.05M shrs ¥3.74B | ||
| 302 |  Zai Lab Limited ZLAB🇺🇸USD | $22.36 | -2.95% | +3.57% | $2.78B €2.48B | 648.46K shrs $14.5M | |
| 303 | ¥23.63 | -0.55% | +16.69% | ¥20.08B $2.77B · €2.48B | 15.85M shrs ¥374.59M | ||
| 304 | kr 319.40 | -0.25% | +4.09% | kr 28.35B $2.75B · €2.46B | 156.97K shrs kr 50.14M | ||
| 305 | ₹837.35 | -0.37% | +4.24% | ₹228.41B $2.74B · €2.45B | 508.57K shrs ₹425.85M | ||
| 306 | Hypera S.A. HYPE3.SA🇧🇷BRL | R$21.52 | -1.01% | +1.82% | R$15.15B $2.73B · €2.44B | 8.18M shrs R$175.94M | |
| 307 | ¥22.31 | -3.67% | +7.41% | ¥19.71B $2.72B · €2.43B | 33.17M shrs ¥740.05M | ||
| 308 | ¥16.39 | -1.97% | +2.24% | ¥19.6B $2.70B · €2.42B | 11.18M shrs ¥183.16M | ||
| 309 | kr 247.80 | -3.05% | +4.88% | kr 18.52B $2.70B · €2.42B | 248K shrs kr 61.45M | ||
| 310 | ¥4205.00 | -0.38% | +3.86% | ¥399.32B $2.68B · €2.40B | 402.2K shrs ¥1.69B | ||
| 311 | HK$11.65 | +2.01% | +10.94% | HK$20.59B $2.64B · €2.36B | 6.3M shrs HK$73.41M | ||
| 312 | $11.75 | +4.17% | -0.92% | $2.63B €2.36B | 2.74M shrs $32.24M | ||
| 313 | HK$69.70 | +0.50% | +24.78% | HK$20.53B $2.63B · €2.35B | 10.61M shrs HK$739.58M | ||
| 314 | $54.54 | +0.70% | +20.54% | $2.63B €2.35B | 257.17K shrs $14.03M | ||
| 315 | R 2.10 | -2.38% | +0.33% | R 48.63B $2.63B · €2.35B | 2.74M shrs R 575.07M | ||
| 316 | ¥11.51 | -5.42% | +6.63% | ¥18.41B $2.54B · €2.27B | 53.09M shrs ¥611.11M | ||
| 317 | $4.24 | -2.53% | +16.14% | $2.53B €2.27B | 20.57M shrs $87.2M | ||
| 318 | HK$22.22 | +0.63% | -0.08% | HK$19.73B $2.53B · €2.26B | 870.49K shrs HK$19.34M | ||
| 319 | ¥73.80 | -5.74% | +4.92% | ¥18.23B $2.52B · €2.25B | 7.07M shrs ¥522.06M | ||
| 320 | ¥9.95 | +0.10% | -1.93% | ¥18.2B $2.51B · €2.25B | 14.67M shrs ¥146M | ||
| 321 | Almirall, S.A. ALM.MC🇪🇸EUR | €10.52 | +0.96% | -0.36% | €2.29B $2.50B | 90.57K shrs €952.84K | |
| 322 |  Biohaven Ltd. BHVN🇺🇸USD | $16.49 | +6.25% | +6.63% | $2.49B €2.23B | 2.45M shrs $40.37M | |
| 323 | ¥43.80 | -0.95% | +5.57% | ¥17.88B $2.47B · €2.21B | 3.07M shrs ¥134.43M | ||
| 324 | ¥83.12 | -0.30% | +6.03% | ¥17.72B $2.45B · €2.19B | 3.14M shrs ¥261.4M | ||
| 325 | ₹836.60 | -0.42% | — | ₹203.02B $2.44B · €2.18B | 8K shrs ₹6.69M | ||
| 326 | $41.84 | +1.85% | +6.59% | $2.44B €2.18B | 1.89M shrs $78.88M | ||
| 327 | $20.76 | -1.47% | +12.01% | $2.43B €2.17B | 1.03M shrs $21.36M | ||
| 328 | ¥19.06 | -1.40% | -6.24% | ¥17.52B $2.42B · €2.16B | 16.35M shrs ¥311.55M | ||
| 329 | ¥1.26 | +0.00% | -6.62% | ¥17.42B $2.40B · €2.15B | 142.57M shrs ¥179.64M | ||
| 330 | ¥18.90 | -0.21% | +6.66% | ¥17.41B $2.40B · €2.15B | 3.97M shrs ¥75.01M | ||
| 331 | HK$42.00 | -2.19% | +12.14% | HK$18.63B $2.38B · €2.13B | 1.6M shrs HK$67.18M | ||
| 332 | C$12.13 | +1.85% | +11.43% | C$3.21B $2.38B · €2.13B | 202.48K shrs C$2.46M | ||
| 333 |  Precigen, Inc. PGEN🇺🇸USD | $6.64 | +9.21% | -2.05% | $2.38B €2.13B | 7.73M shrs $51.31M | |
| 334 | $13.59 | +2.03% | +6.10% | $2.36B €2.11B | 33.92K shrs $461.04K | ||
| 335 |  Pharvaris N.V. PHVS🇺🇸USD | $33.58 | +2.32% | +2.29% | $2.36B €2.11B | 877.86K shrs $29.48M | |
| 336 | HK$21.16 | +0.28% | +5.87% | HK$18.39B $2.35B · €2.11B | 2.57M shrs HK$54.38M | ||
| 337 | $29.89 | +0.78% | +11.52% | $2.35B €2.10B | 916.68K shrs $27.4M | ||
| 338 | $18.61 | +1.20% | +2.63% | $2.34B €2.10B | 1.67M shrs $31M | ||
| 339 | ¥40.04 | -2.03% | +16.45% | ¥16.95B $2.34B · €2.09B | 7.97M shrs ¥319.2M | ||
| 340 | $48.75 | +2.01% | +4.58% | $2.31B €2.07B | 343.39K shrs $16.74M | ||
| 341 | $17.21 | -0.86% | -11.63% | $2.29B €2.05B | 744.72K shrs $12.82M | ||
| 342 | $8.62 | +1.65% | -0.77% | $2.28B €2.04B | 15.19K shrs $130.97K | ||
| 343 | ¥98.40 | -2.81% | +18.57% | ¥16.5B $2.28B · €2.04B | 20.88M shrs ¥2.05B | ||
| 344 | $38.59 | +0.23% | +5.39% | $2.25B €2.01B | 778.85K shrs $30.06M | ||
| 345 | kr 232.00 | +1.22% | +4.34% | kr 15.39B $2.25B · €2.01B | 387.3K shrs kr 89.85M | ||
| 346 | SR 119.90 | -1.72% | -2.97% | SR 8.39B $2.24B · €2.01B | 22.4K shrs SR 2.69M | ||
| 347 | £202.00 | -1.94% | +1.58% | £1.76B $2.23B · €2.00B | 16.8K shrs £3.39M | ||
| 348 | $37.23 | -2.33% | +4.19% | $2.22B €1.99B | 851K shrs $31.68M | ||
| 349 | ¥7.19 | -0.28% | -4.18% | ¥16.05B $2.21B · €1.98B | 8.75M shrs ¥62.9M | ||
| 350 | ₹481.35 | +0.95% | +11.09% | ₹184.16B $2.21B · €1.98B | 120.42K shrs ₹57.96M | ||
| 351 | ₹481.35 | +1.11% | -1.45% | ₹184.16B $2.21B · €1.98B | 1.5M shrs ₹719.87M | ||
| 352 | $23.14 | -10.61% | +6.80% | $2.2B €1.97B | 4.95M shrs $114.55M | ||
| 353 | $30.53 | -1.33% | +11.68% | $2.2B €1.97B | 1.11M shrs $33.81M | ||
| 354 | $15.90 | -0.13% | +8.64% | $2.2B €1.97B | 2.29M shrs $36.39M | ||
| 355 | $42.91 | +4.43% | +11.79% | $2.2B €1.97B | 544.83K shrs $23.38M | ||
| 356 | ₹935.60 | +0.39% | -3.45% | ₹182.99B $2.20B · €1.97B | 385.74K shrs ₹360.9M | ||
| 357 | ₹935.10 | +0.38% | +4.56% | ₹182.89B $2.19B · €1.96B | 36.33K shrs ₹33.97M | ||
| 358 | $151.58 | +2.79% | +16.50% | $2.18B €1.96B | 342.95K shrs $51.98M | ||
| 359 | $8.52 | +1.79% | +3.65% | $2.18B €1.95B | 4.52M shrs $38.49M | ||
| 360 | ¥15.17 | -2.32% | +0.06% | ¥15.76B $2.17B · €1.95B | 11.92M shrs ¥180.84M | ||
| 361 |  Xencor, Inc. XNCR🇺🇸USD | $29.21 | -2.60% | +9.23% | $2.17B €1.94B | 930.42K shrs $27.18M | |
| 362 | ₹2376.10 | +0.56% | +2.93% | ₹180.61B $2.17B · €1.94B | 85.56K shrs ₹203.29M | ||
| 363 | ₹2373.60 | +0.47% | +1.07% | ₹180.42B $2.17B · €1.94B | 7.11K shrs ₹16.87M | ||
| 364 | ₹1569.65 | -0.24% | +2.17% | ₹180B $2.16B · €1.93B | 23.38K shrs ₹36.7M | ||
| 365 | ₹1569.60 | -0.51% | +2.19% | ₹179.99B $2.16B · €1.93B | 736.96K shrs ₹1.16B | ||
| 366 |  Immunome, Inc. IMNM🇺🇸USD | $18.29 | -2.51% | +11.17% | $2.16B €1.93B | 877.8K shrs $16.05M | |
| 367 | $32.33 | +0.78% | +1.89% | $2.13B €1.91B | 245.96K shrs $7.95M | ||
| 368 | S$12.99 | +0.85% | -2.55% | S$2.88B $2.13B · €1.90B | 9.03K shrs S$117.3K | ||
| 369 | ¥14.59 | -0.34% | -1.57% | ¥15.39B $2.12B · €1.90B | 4.08M shrs ¥59.52M | ||
| 370 |  Septerna, Inc. SEPN🇺🇸USD | $45.23 | +2.21% | -5.36% | $2.11B €1.89B | 200.62K shrs $9.07M | |
| 371 | ¥7.78 | +2.64% | +5.46% | ¥15.24B $2.10B · €1.88B | 24.62M shrs ¥191.57M | ||
| 372 | MX$416.75 | +0.46% | +0.16% | MX$40.33B $2.10B · €1.88B | 457 shrs MX$190.45K | ||
| 373 | HK$15.88 | -1.12% | +3.29% | HK$16.29B $2.09B · €1.87B | 1.1M shrs HK$17.46M | ||
| 374 | €38.55 | +0.92% | — | €1.91B $2.08B | 17.67K shrs €681.22K | ||
| 375 | $12.10 | +1.85% | +49.93% | $2.08B €1.86B | 4.3M shrs $52.07M | ||
| 376 | €28.90 | +1.19% | +2.52% | €1.9B $2.08B | 102.23K shrs €2.95M | ||
| 377 | ¥12.72 | -5.07% | +6.36% | ¥15.01B $2.07B · €1.85B | 44.66M shrs ¥568.07M | ||
| 378 | ₹3760.40 | +0.95% | — | ₹172.21B $2.07B · €1.85B | 649 shrs ₹2.44M | ||
| 379 |  Zymeworks Inc. ZYME🇺🇸USD | $28.71 | -0.66% | +7.71% | $2.06B €1.85B | 806.17K shrs $23.15M | |
| 380 | ₹3759.80 | +0.68% | -0.52% | ₹172B $2.06B · €1.85B | 13.54K shrs ₹50.9M | ||
| 381 | ₹1397.75 | -0.20% | +4.78% | ₹171.6B $2.06B · €1.84B | 15.49K shrs ₹21.65M | ||
| 382 | ₹1397.40 | -0.14% | +5.12% | ₹171.56B $2.06B · €1.84B | 264.3K shrs ₹369.33M | ||
| 383 | ¥31.63 | -1.77% | +9.94% | ¥14.88B $2.05B · €1.84B | 1.6M shrs ¥50.51M | ||
| 384 | $10.15 | -2.17% | +46.31% | $2.05B €1.84B | 8.22M shrs $83.5M | ||
| 385 | $15.67 | +17.03% | -8.39% | $2.03B €1.82B | 696.47K shrs $10.91M | ||
| 386 | $19.23 | -0.47% | +5.45% | $2.03B €1.82B | 1.19M shrs $22.79M | ||
| 387 | $15.77 | +2.54% | +6.93% | $2.02B €1.81B | 1.74M shrs $27.45M | ||
| 388 |  HitGen Inc. 688222.SS🇨🇳CNY | ¥36.43 | -0.05% | +8.39% | ¥14.61B $2.02B · €1.81B | 29.66M shrs ¥1.08B | |
| 389 | Rp 715.00 | -2.72% | +0.66% | Rp 32.35T $2.01B · €1.80B | 32.65M shrs Rp 23.35B | ||
| 390 | $11.75 | -1.51% | -5.91% | $1.99B €1.78B | 1.42M shrs $16.7M | ||
| 391 | $13.81 | +2.14% | +1.32% | $1.97B €1.76B | 1.35M shrs $18.58M | ||
| 392 | $10.75 | +1.03% | +11.11% | $1.96B €1.75B | 1.74M shrs $18.75M | ||
| 393 | ¥22.08 | +0.59% | -5.38% | ¥14.03B $1.94B · €1.73B | 3.81M shrs ¥84.14M | ||
| 394 | HK$4.32 | -0.58% | -1.88% | HK$15.13B $1.94B · €1.73B | 3.6M shrs HK$15.54M | ||
| 395 | ¥12.61 | -0.79% | -0.67% | ¥13.98B $1.93B · €1.73B | 14.4M shrs ¥181.55M | ||
| 396 | ¥14.30 | -3.38% | -21.77% | ¥13.82B $1.91B · €1.71B | 9.63M shrs ¥137.71M | ||
| 397 | $45.23 | -1.08% | +4.56% | $1.9B €1.70B | 471.53K shrs $21.32M | ||
| 398 | A$2.25 | -3.23% | -8.07% | A$2.92B $1.89B · €1.70B | 1.36M shrs A$3.05M | ||
| 399 | ₹6299.00 | +0.99% | -4.59% | ₹157.47B $1.89B · €1.69B | 5.61K shrs ₹35.36M | ||
| 400 | $40.42 | +4.99% | +11.49% | $1.89B €1.69B | 1.2M shrs $48.34M |
Browse by Country
Europe
Asia